Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Sinomune Pharmaceutical Co., Ltd.

Home Clinical Trial Sponsors and OrganizationsSinomune Pharmaceutical Co., Ltd.

Sinomune Pharmaceutical Co., Ltd.

ACTIVE

No.35, Jingxin Road, Industrial Park, Xibei Town, Xishan District, 江苏省无锡市, 江苏省, Chinawww.sinomunepharma.com/index.aspxHoldingEstablished: 1999-03-11

Part of wuxi zhonghe pharmaceutical investment co., ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1999

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

2

66.7%

Phase 3

1

33.3%

Trial Status Distribution

Completed

1

33.3%

Recruiting

2

66.7%

Clinical Trials

Trials sponsored by this organization (3)

A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes

Jul 202664 participants

ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis

Apr 202648 participants

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

May 2019239 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations